3 participants
Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-12-03
- Start Date:
- 2024-11-08
- Completion:
- 2026-09-30
Conditions
- Crigler-Najjar Syndrome
Interventions
- DRUG
No Results Yet